A study on new antiepileptic drug levetiracetam in patients with epilepsy surgery
- Conditions
- epilepsy
- Registration Number
- JPRN-UMIN000006703
- Lead Sponsor
- Graduates School of Biomedical Sciences, Department of Neurosurgery, Hiroshima University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 10
Not provided
Patients already administered levetiracetam before starting the test drugs. Patients with a history of hypersensitivity for ingredients of the test drugs or pyrrolidone derivatives. Patients with psychiatric disease, progressive neurological disorder and other serious complications. Patients during administering other investigational or unapproved drugs within three months before starting a follow-up. Patients with clinical trials of levetiracetam in the past. Patients with levetiracetam discontinued because of the side effects in the past. Patients with non (or potential of non)-compliance to regular medication or doctor consultation appointments. Pregnant or potentially pregnant women, breast-feeding women. Patients considered to be inappropriative for carrying out the trials by attending physicians.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ong-term tolerability of levetiracetam in patients with epilepsy surgery
- Secondary Outcome Measures
Name Time Method